PHARMA THE LAND
TBY talks to Jiri Urbanec, General Director & CEO of SANTO, on the environment in Kazakhstan, investment programs, and new pharmaceutical regulations.
BIOGRAPHY
Jiri Urbanec has held the position of SANTO CEO since October 1st, 2015. He graduated from Technical University in Ostrava, Czech Republic and has an MBA from Liverpool John Moores University. He also holds a Master’s in International Bilateral Management from the Technical University in Brno, Czech Republic and University of M. Kopernik in Torun, Poland. Before SANTO, Urbanec worked at several international pharmaceutical companies.What brought you to Kazakhstan and what do you expect to achieve within your role as CEO?
I have experience working in many countries, but Kazakhstan is the one that I like the most. This is a country with a great history, amazing culture, beautiful nature, and wonderful people. SANTO is a leading pharmaceutical company in Kazakhstan in monetary terms according to IMS Health data for 2015. We want to maintain this position and ensure our primacy by gaining a more substantial share of the market. Currently, we are in the process of doubling our business over the next three to four years. This means doubling revenue, the size of the company, and the size of our facilities. We are also working to modernize our portfolio by adding new products and registering a number of modern products while concurrently improving the position of traditional Kazakhstani brands, like Mukaltin, which people believe in. One of our best sellers is Mukaltin, which is a traditional cough remedy. We are strong in sterile antibiotics and pediatrics, and these are our other biggest areas of business. Thanks to these new products and the portfolio that we are developing, we have become the largest supplier to the government healthcare system. It now recognizes that the pharmaceutical sector is one of key industries and that it should support local business to ensure that they have quality pharmaceutical production. We are also going to enter complex therapeutic fields such as oncology biosimilars, as modern treatments are moving in that direction.
SANTO is investing more than $100 million into the modernization and construction of new facilities. What are your main projects in this regard?
As of September 2011, SANTO is a part of international pharmaceutical company Polpharma Group, which has an investment project in Kazakhstan amounting to more than $100 million. The main purpose of the investment project is to modernize the operation facilities within GMP quality standards. This project will significantly reduce the costs of the healthcare system in Kazakhstan and ensure access to high-quality and affordable medicines for more patients in Kazakhstan. SANTO has already obtained GMP quality certificates for the production lines of liquid sterile dosage forms in a new unique ampoule-infusion workshop where more than $40 million was invested. Currently, we are in the process of realizing a new shop aseptic antibiotics powder filling, which is scheduled for completion in May 2016. Many companies usually opt for tablet production because they are less expensive and easier to deal with, so we will be one of the few, or maybe the only company, to offer all pharmaceutical types, including sterile and tablets. There is an opportunity for us to take these products and market them for larger players.
In 2016, within the Eurasian Economic Union, new regulations in the pharmaceutical industry will be implemented. As a company that exports to five countries, how will this affect your business?
As always, it is both a threat and opportunity. The threat is that opportunities will arise for lower-quality manufacturers from other countries, i.e. members of the Eurasian Economic Union. At the same time, it may be an opportunity as the Eurasian Economic zone will be a key market and we may be given priority and preference as a local supplier. We are not afraid and see the situation as more of an opportunity than anything else. If we make smart moves, we stand to benefit from the situation. We are a local Kazakhstani manufacturer but we are part of the international group and our production is set on its investments and experience. We are heavily involved in Kyrgyzstan, where we will double our operations next year, and we have penetrated the Turkmenistan market by being accepted as a Kazakhstani manufacturer. We consider this a huge success because it only accepts European manufacturers. Once again, Russia remains the main market that we plan on entering. We are working heavily to move into Russia as a Kazakhstani manufacturer. The Kazakhstani market is 10 times bigger and we have the best manufacturing plant in the Eurasian region. By capitalizing on these strengths, we will become international. We want to be an important regional player, and aim to sell at least one product in Europe. By doing this we will prove that our products meet international standards. I would like to create additional manufacturing facilities in our factory in Shymkent.
PHARMA THE LAND
TABLE OF CONTENTS
Year In Review
Vast Potential
<strong>Kazakhstan's increasingly diversified economy makes the country well placed to weather the dual storms of low energy and low commodity prices. The country is ever more closely aligned to China, its eastern neighbour, with mining, ICT, and construction set to benefit.</strong>
read articleInterview
İnci Doğusan, Vice President Russia, Turkey & Caspian Sea Region, Bureau Veritas
TBY talks to İnci Doğusan, Vice President Russia, Turkey & Caspian Sea Region of Bureau Veritas, on recent success, sectors of interest, and the particular challenges faced by international companies.
read articleFocus: Astana International Finance Center
A league Ahead
The government is planning to turn the EXPO 2017 grounds into a free trade zone when the event is over. The environment is becoming increasingly welcoming to investors, but will Astana be able to follow through with its plans this time around?
read articleFocus: Kashagan
The Largest Field
A major reef structure in the Caspian Sea close to Atyrau City, Kazakhstan's Kashagan field was identified between 1988-1991 as a result of exploratory seismic work. Between 45 to 75km in circumference, it is estimated to contain more than 4.5 billion tons of oil.
read articleReview: Industry
Factory Reset
In 2015, industry accounted for 28% of the country's GDP for that year, and the sector is growing strongly. In 2013, industrial exports passed the $3 billion mark for the first time, and since then efforts to diversify the country's industrial mix have come to the fore.
read articleFocus: Made in Kazakhstan
We Made it!
Local products have had a hard time taking off and gaining popularity within Kazakhstan. However, a newly energized “Made in Kazakhstan” campaign, as well as support for local producers from the president, are poised to bring Kazakh products to the front of the shelves.
read articleInterview
Steve Brown, Group Managing Partner, Cushman Wakefield | Veritas Brown (CW|VB
TBY talks to Steve Brown, Group Managing Partner at Cushman Wakefield | Veritas Brown (CW|VB), on becoming the preferred real estate services company in Kazakhstan, the firm's current projects, and the long-term development of the country.
read articleReview: Agriculture
Land Unlocked
Farming stretches as far back into Kazakhstan's history as it does across the vastest steppe, and agriculture forms an important part of the nation's identity to this day. The traditional mainstay of wheat, now deliberately in decline, is being joined by an effort to diversify the agricultural basket with the aim of year-round food security.
read articleFocus: Dairy Expansion
Milking It
Efforts are underway to increase Kazakhstan's dairy production capacity, particularly its domestic milk production. With agriculture a key sector for growth and investor opportunities, the dairy sector finds itself at the forefront of a radical change in central policy.
read articleFocus: Bolashak International Scholarship
Education without Borders
Back in the 1990s, Kazakhstan was the first Central Asian country to launch an all-expenses paid presidential scholarship program for international study, thanks to which, for the first time in the history of the post-Soviet countries, talented, high-performing students have the chance to study abroad.
read articleFocus: Universiade 2017
Game On
The Winter Universiade will be broadcast by more than 100 TV channels around the world. The event will attract a number of international visitors, boosting Almaty's reputation as a tourist destination and initiating the renovation and construction of infrastructure, hotels, and ski resorts.
read article